Endometrial Cell Collection With the PadKit
Completed · Not applicable
Conditions studied: Neoplasms
In brief
All patients will be provided with a Preprogen Pad to be worn for 4-6 hours to collect cells shed by the endometrium. After the kit is returned to the Preprogen laboratory, a brief survey will be completed. Analysis will be conducted to determine if the PadKit™ can collect a sample of endometrial cells sufficient to differentiate between normal and atypical hyperplasia/malignant cells in blinded samples provided to the laboratory for analysis.
Key facts
- Study ID
- NCT06464107
- Run by
- Hackensack Meridian Health
- People needed
- 80
- Starts
- 2024-05-31
- Expected to finish
- 2026-04-17
- Last updated by the study team
- 2026-05-13
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Women who present to Gynecologic Oncology for surgical intervention and have not undergone prior hysterectomy.
- Cohort 1: has biopsy proven atypical hyperplasia or endometrial cancer.
- Cohort 2: women with planned hysterectomy for benign clinical indications
You may not qualify if…
- Unable to provide informed consent
- Women who have previously undergone uterine surgery (subtotal, or supracervical hysterectomy).
Where it is running
- Jersey Shore University Medical Center — Neptune City, New Jersey, United States
- Riverview Medical Center — Red Bank, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.